Z. Herrmann

Roche (United States) — United States

Medicine · Health Sciences

9h-index785citations18works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bone health and treatments(8), Medical Imaging and Pathology Studies(3), Multiple Myeloma Research and Treatments(2), Metabolism and Genetic Disorders(2), Peptidase Inhibition and Analysis(2)

Publications18 total

Efficacy and Safety of Recombinant Human Erythropoietin to Prevent the Anaemias of Prematurity
Contributions to nephrology·2015· 56 citedOpen Access
Reference Change Values for Brain Natriuretic Peptides Revisited
Clinical Chemistry·2006· 170 citedOpen Access
The influence of renal function on NT-proBNP levels in various disease groups.
PubMed·2003· 21 cited
Effects of Long-Term Intravenous Ibandronate Therapy on Skeletal-Related Events, Survival, and Bone Resorption Markers in Patients With Advanced Multiple Myeloma
Journal of Clinical Oncology·2002· 159 cited
Serum Parathyroid Hormone-Related Protein Levels and Response to Bisphosphonate Treatment in Hypercalcemia of Malignancy
The Journal of Clinical Endocrinology & Metabolism·1999· 47 citedOpen Access
Industrial Forum · Industrieforum
Oncology Research and Treatment·1999Open Access
Band 22, Heft 3, Juni 1999
Oncology Research and Treatment·1999Open Access
Book Reviews · Buchbesprechungen
Oncology Research and Treatment·1999Open Access
The New Bisphosphonate Ibandronate in the Treatment of Tumor-Induced Hypercalcemia
Oncology Research and Treatment·1999· 9 cited
Meetings and Conferences · Tagungen und Kongresse
Oncology Research and Treatment·1999Open Access
[Osteoporosis in multiple myeloma].
PubMed·1998· 2 cited
Dose-response study of ibandronate in the treatment of cancer-associated hypercalcaemia
British Journal of Cancer·1997· 130 citedOpen Access
Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancy.
Journal of Clinical Oncology·1996· 127 cited
Pathophysiology of malignant hypercalcemia in relation with serum parathyroid hormone-related protein levels and response to the bisphosphonate ibandronate
Bone·1995· 2 cited
Prospective Randomized Trial of Dichloromethylene Bisphosphonate (Clodronate) in Patients with Multiple Myeloma Requiring Treatment. A Multicenter Study
Oncology Research and Treatment·1995· 52 cited
Industrial Forum – Industrieforum
Oncology Research and Treatment·1995· 1 citedOpen Access
Instructions to Authors
Oncology Research and Treatment·1995Open Access
63 RECOMBINANT HUMAN ERYTHROPOIETIN (rhEPO) FOR PREVENTION OF ANAEMIAS OF PREMATURITY: A RANDOMIZED MULTICENTRE TRIAL
Pediatric Research·1990· 9 citedOpen Access

Frequent Co-authors

Martin Pecherstorfer(5), Ch. Boewer(5), K.-H. Schöter(5), D. Thiébaud(4), B. Thürlimann(4), M.E. Heim(4), L. Edler(4), G. Riethmüller(4), G. Deplanque(4), C. Giron(4), B. Lioure(4), J.M. Limacher(4), Raoul Herbrecht(4), A. Laplace(4), P. Dufour(4), Mark Bischof(4), D. Latz(4), M. Wannenmacher(4), R. Hartenstein(4), B.K. Dallaire(4)